Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Not Confirmed
Not Confirmed
08-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
CPhI Middle EastCPhI Middle East
Industry Trade Show
Not Confirmed
08-10 December, 2025
Digital content

10 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-announces-leadership-transition-and-strategic-appointments-to-support-uk-commercialization-strategy-302425126.html

07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-announces-first-patient-dosed-in-us-in-phase-1-study-for-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302343020.html

10 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-raises-16-million-in-series-b-financing-to-advance-lead-asset-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302326459.html

21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-ceo-speaks-at-fda-and-nih-public-meeting-to-encourage-innovation-of-smoking-cessation-treatment-options-302280571.html

01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-announces-fda-clearance-of-ind-application-for-lead-asset-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302263046.html

08 Aug 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/developers-vapes-migraine-asthma-will-need-win-over-sceptics-2024-08-09/
ABOUT THIS PAGE